PlainPharmaWatch

CMS Open Payments · Tool

American Rheumatology Network, LLC vs Philips North America LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

American Rheumatology Network, LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 3,431, versus 59 for the other company. Its single largest recorded recipient represents 53.5% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

American Rheumatology Network, LLC
HHI 3,431 · top recipient 53.5%
Ranked #515 of 1,838 companies by HHI
Philips North America LLC
HHI 59 · top recipient 4.4%
Ranked #1,751 of 1,838 companies by HHI

Payment Overview

Total Payments
$15.9M
% of Industry
0.1%
Transactions
18
Avg per Transaction
$884.4K
Recipients
12
Avg per Recipient
$1.3M
Payment Types
2
Top Payment Type
Acquisitions
Total Payments
$15.7M
% of Industry
0.1%
Transactions
35,552
Avg per Transaction
$440.98
Recipients
35,252
Avg per Recipient
$444.73
Payment Types
14
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

American Rheumatology Network, LLC vs Philips North America LLC - total reported payments in CMS Open Payments PY2024

American Rheumatology Netwo…$15.9MPhilips North America LLC$15.7M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

American Rheumatology Network, LLC

Acquisitions $1.5M

53.5%

Consulting Fee $1.3M

46.5%

Philips North America LLC

Consulting Fee $2.3M

36.8%

Travel and Lodging $1.4M

22.9%

Food and Beverage $920.6K

14.8%

Honoraria $810.0K

13.0%

Royalty or License $424.2K

6.8%

Space Rental or Facility Fees $138.2K

2.2%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

American Rheumatology Network, LLC

  1. 1

    COLIN EDGERTON

    $1,500,000.00 · 1 txns

  2. 2

    CLARENCE LEGERTON

    $432,646.53 · 3 txns

  3. 3

    GARY FINK

    $432,646.53 · 3 txns

  4. 4

    WILLIAM EDWARDS

    $204,120.88 · 3 txns

  5. 5

    GREGORY NIEMER

    $116,071.43 · 1 txns

Philips North America LLC

  1. 1

    Dana-Farber Cancer Institute

    $271,390.00 · 4 txns

  2. 2

    SHEPHAL DOSHI

    $102,703.50 · 49 txns

  3. 3

    EDRIS AMAN

    $87,970.57 · 33 txns

  4. 4

    GAGAN SINGH

    $87,304.12 · 38 txns

  5. 5

    RICHARD BARR

    $84,696.14 · 64 txns

Summary Comparison

Metric American Rheumatology Network, LLC Philips North America LLC
Total Payments $15.9M $15.7M
% of Industry Total 0.1% 0.1%
Transaction Count 18 35,552
Avg per Transaction $884.4K $440.98
Recipient Count 12 35,252
Avg per Recipient $1.3M $444.73
Payment Type Count 2 14
Top Payment Type Acquisitions Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.